Literature DB >> 8061336

Psychological distress and levels of disease activity in inflammatory bowel disease.

P Porcelli1, S Zaka, S Centonze, G Sisto.   

Abstract

The aim of this study was to evaluate the association between anxiety and depression, and levels of disease activity (LDA) in IBD patients. One hundred and fifty IBD patients (91 males and 59 females) were assessed by means of the Hospital Anxiety and Depression scale, and divided into three LDA groups according to standard clinical criteria: LDA1 = absence, LDA2 = mild, LDA3 = moderate and severe. Using the analysis of variance and the Scheffé test, a significant difference was found in the anxiety score, but not in the depression score, between LDA1 and LDA3 (p < 0.005). The risk of developing anxiety and depression in relation to LDA was estimated by multiple logistic regression. A significant linear trend (p < 0.01) to develop anxiety was found in the highest LDA. Our study showed that anxiety was significantly associated with a higher disease activity and suggested that anxiety should be appropriately evaluated and treated with the exacerbated symptoms in IBD patients.

Entities:  

Mesh:

Year:  1994        PMID: 8061336

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  12 in total

1.  Crohn's disease complicated by central serous retinopathy.

Authors:  G A Paspatis; P Koutentakis; K Triantafyllou; N Papanikolaoy; M Prinianaki; C Fanoyriakis
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 2.  Exercise and Crohn's disease: speculations on potential benefits.

Authors:  Victor Ng; Wanda Millard; Constance Lebrun; John Howard
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

3.  Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.

Authors:  Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

4.  Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress.

Authors:  Robert G Maunder; Gordon R Greenberg; Jonathan J Hunter; William J Lancee; A Hillary Steinhart; Mark S Silverberg
Journal:  Am J Gastroenterol       Date:  2006-10-04       Impact factor: 10.864

5.  Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.

Authors:  Ekaterini Chatzaki; Peter A Anton; Mulugeta Million; Maria Lambropoulou; Theodoros Constantinidis; George Kolios; Yvette Taché; Dimitri E Grigoriadis
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

6.  Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity.

Authors:  Houssam E Mardini; Kevin E Kip; John W Wilson
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

7.  The influence of depression on quality of life in patients with inflammatory bowel disease.

Authors:  Clarence K Zhang; Jennifer Hewett; Jason Hemming; Taneisha Grant; Hongyu Zhao; Clara Abraham; Ioannis Oikonomou; Meera Kanakia; Judy H Cho; Deborah D Proctor
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

8.  The causal representation of outpatients with Crohn's disease: is there a link between psychological distress and clinical disease activity?

Authors:  Ingrid Banovic; Daniel Gilibert; Anne Andronikof; Ahmed Jebrane; Ivan Ajdukovic; Jaques Cosnes
Journal:  Psychosoc Med       Date:  2013-12-16

9.  Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort.

Authors:  Davina Tribbick; Michael Salzberg; Maria Ftanou; William R Connell; Finlay Macrae; Michael A Kamm; Glen W Bates; Georgina Cunningham; David W Austin; Simon R Knowles
Journal:  Clin Exp Gastroenterol       Date:  2015-07-17

Review 10.  The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Tony Long; Daniel van Langenberg
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.